This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain
NCT ID: NCT03993119
Last Updated: 2021-09-29
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2019-07-30
2020-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
This Study Observes the Use of New Oral Anticoagulants (NOACs) in Patients With a Heart Rhythm Disorder in Spain
NCT03285373
Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial Fibrillation
NCT01199081
Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation
NCT03570047
Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure
NCT03508271
Study of Normal Conditions of Use, Dosing, and Safety of Intravenous (IV) Administration of Vernakalant (MK-6621-049)
NCT01370629
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with NVAF
Non-vitamin K antagonist oral anticoagulant
Non-vitamin K antagonist oral anticoagulant
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-vitamin K antagonist oral anticoagulant
Non-vitamin K antagonist oral anticoagulant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients ≥ 75 years-old at the time of the study visit.
* Patients with a diagnosis of non-valvular atrial fibrillation (NVAF).
* Patients who are being treated with NOAC treatment according to the indication approved in the Summary of Product Characteristics (SmPC).
* Patients who have started the NOAC treatment at least 3 months prior to the study visit.
Exclusion Criteria
* Current participation in any clinical trial of a drug or device.
* Patients who have any contraindication for NOAC treatment, according to the SmPC.
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boehringer Ingelheim
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
H. Fundación Alcorcón
Alcorcón, Madrid, , Spain
Consulta Privada
Almería, , Spain
H. Dr. José Molina Orosa
Arrecife, Las Palmas, , Spain
Centro Médico San Juan de Dios
Barakaldo, Bizkaia, , Spain
H. Sagrat Cor
Barcelona, , Spain
H. Vall d'Hebron
Barcelona, , Spain
H. Sant Pau
Barcelona, , Spain
H. Vithas Internacional Xanit
Benalmádena, Málaga, , Spain
Ambulatorio Txurdinaga
Bilbao, , Spain
H. San Juan de Dios de Bormujos
Bormujos, Sevilla, , Spain
H. Provincial de Castellón
Castellon, , Spain
H. San Pedro Alcántara
Cáceres, , Spain
Consulta privada Dr. Ruiz
Córdoba, , Spain
H. Arquitecto Marcide
Ferrol, A Coruña, , Spain
H. de Jaen
Jaén, , Spain
H. U. de León
León, , Spain
H. Arnau de Vilanova
Lleida, , Spain
H. Lucus Augusti
Lugo, , Spain
H. La Princesa
Madrid, , Spain
Sanitas La Zarzuela
Madrid, , Spain
H. Central de la Defensa Gómez
Madrid, , Spain
H. Puerta de Hierro
Majadahonda, Madrid, , Spain
H. de Mataró
Mataró, Barcelona, , Spain
Consulta Privada
Málaga, , Spain
H. de Mendaro
Mendaro, Guipúzcoa, , Spain
H. Morales Meseguer
Murcia, , Spain
H. Virgen de la Arrixaca
Murcia, , Spain
Consulta privada Merelles Otero
Ourense, , Spain
Consulta Privada
Ourense, , Spain
H. Río Carrión
Palencia, , Spain
H. Son Llatzer
Palma de Mallorca, , Spain
H. de Navarra
Pamplona, , Spain
H. Comarcal de la Vega Baja
San Bartolomé, Alicante, , Spain
H. Moises Broggi
Sant Joan Despí, Barcelona, , Spain
H. Marqués de Valdecilla
Santander, , Spain
H. Álvarez-Buylla
Santullano, Asturias, , Spain
H. Virgen de la Macarena
Seville, , Spain
H. Virgen del Valle
Toledo, , Spain
H. de Torrejón
Torrejón de Ardoz, Madrid, , Spain
Consulta Privada
Valencia, , Spain
H. General de Valencia
Valencia, , Spain
Hospital La Fe
Valencia, , Spain
H. Virgen de la Concha
Zamora, , Spain
H. Clínico Lozano Blesa
Zaragoza, , Spain
H. Miguel Servet
Zaragoza, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1160-0297
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.